Man Group
XGN icon

Man Group’s Exagen XGN Stock Holding History

Man Group’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$778K Buy
167,292
+37,582
+29% +$142K ﹤0.01% 1934
2026
Q1 		$389K Buy
129,710
+97,104
+298% +$376K ﹤0.01% 2146
2025
Q4 		$198K Buy
+32,606
New +$297K ﹤0.01% 2126

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Man Group's XGN Position: Q2 2026 in Review

Man Group increased its Exagen (XGN) stake by 29% in Q2 2026, buying an estimated $142K and bringing the position to 167,292 shares worth $778K. The position accounts for ﹤0.01% of the portfolio, ranked #1934.

Man Group first reported a position in XGN in Q4 2025 and has held it in 3 quarters since. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Man Group held 167,292 shares of Exagen worth $778K as of Q2 2026.
  • Man Group bought 37,582 Exagen shares in Q2 2026, an estimated $142K.
  • Exagen made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1934 holding.
  • Man Group first reported a position in Exagen in Q4 2025 and has held it in 3 quarters since.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.